We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Short-term Structured Exercise Training Program Plus Diet Intervention in Patients With Polycystic Ovary Syndrome (PCOS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01004068
First Posted: October 29, 2009
Last Update Posted: November 3, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Magna Graecia
  Purpose
Clomiphene citrate (CC) is the first-line therapy for infertile women with polycystic ovary syndrome (PCOS). Unfortunately, at least 20% of PCOS results are not responsive to CC. Structured exercise training (SET) and diet has been successfully employed to restore ovarian function and to improve reproductive outcomes in obese and overweight women with PCOS. The current study was aimed to test the hypothesis that a short-term SET program plus diet intervention can improve the ovarian response to CC in CC-resistant PCOS patients.

Condition Intervention Phase
Polycystic Ovary Syndrome Anovulation Other: SET-diet plus clomiphene Drug: Clomiphene citrate Behavioral: Structured exercise program plus hypocaloric diet Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Does Short-term Structured Exercise Training Program Plus Diet Intervention Improve Ovarian Sensitivity to Clomiphene Citrate in Polycystic Ovary Syndrome Patients (PCOS)? A Prospective Randomized Controlled Study

Resource links provided by NLM:


Further study details as provided by University Magna Graecia:

Primary Outcome Measures:
  • Ovulation rate [ Time Frame: three months ]

Secondary Outcome Measures:
  • Clinical data [ Time Frame: three months ]
  • Metabolic data [ Time Frame: three months ]

Enrollment: 96
Study Start Date: February 2008
Study Completion Date: October 2009
Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: SET-diet plus clomiphene
Structured exercise program plus hypocaloric diet for two months and received one-cycle of clomiphene citrate for one cycle
Other: SET-diet plus clomiphene
Two months of structured exercise program plus hypocaloric diet followed by 150 mg daily of clomiphene citrate
Other Names:
  • Lifestyle modification
  • CC
Active Comparator: Clomiphene citrate
One month of observation followed by one-cycle of clomiphene citrate therapy
Drug: Clomiphene citrate
Clomiphene citrate at 150 mg daily for one cycle
Other Name: CC
Experimental: SET plus diet
Lifestyle modifications for two months.
Behavioral: Structured exercise program plus hypocaloric diet
SET plus diet
Other Name: Lifestyle modifications

Detailed Description:
Ninety-six PCOS patients considered CC-resistant because not responsive to 150 mg daily of CC were randomized in three arms (group A, B, and C). Group A underwent SET program plus hypocaloric diet for two months, group B had one month of observation followed by one-cycle of CC therapy, and group C underwent SET program plus hypocaloric diet for two months and received one-cycle of CC for one cycle. CC was always given at the maximal dose previously used. Clinical, hormonal and metabolic data were assessed at baseline and after intervention. Ovulation was monitored by ultrasound and confirmed by plasma progesterone assay.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • PCOS
  • Anovulation

Exclusion Criteria:

  • Major Medical Condition
  • Severe Obesity
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01004068


Locations
Italy
"Pugliese" Hospital
Catanzaro, Italy, 88100
Sponsors and Collaborators
University Magna Graecia
Investigators
Principal Investigator: Stefano Palomba, MD University Magna Graecia
  More Information

Publications:
Responsible Party: Department of Obstetrics and Gynecology, University Magna Graecia of Catanzaro
ClinicalTrials.gov Identifier: NCT01004068     History of Changes
Other Study ID Numbers: 06/2009
First Submitted: July 15, 2009
First Posted: October 29, 2009
Last Update Posted: November 3, 2010
Last Verified: November 2009

Keywords provided by University Magna Graecia:
Clomiphene
Diet
Exercise
Infertility
PCOS
Physical activity
Treatment

Additional relevant MeSH terms:
Syndrome
Polycystic Ovary Syndrome
Anovulation
Disease
Pathologic Processes
Ovarian Cysts
Cysts
Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases
Citric Acid
Clomiphene
Enclomiphene
Zuclomiphene
Anticoagulants
Calcium Chelating Agents
Chelating Agents
Sequestering Agents
Molecular Mechanisms of Pharmacological Action
Estrogen Antagonists
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Fertility Agents, Female
Fertility Agents
Reproductive Control Agents
Selective Estrogen Receptor Modulators